Anticancer Drug Development: the Grand Challenges

Overview

Journal Nat Rev Drug Discov

Specialty Pharmacology

Date 2010 Apr 7

PMID 20369394

Citations 83

Authors

William N Hait

Affiliations

Soon will be listed here.

Abstract

Despite vast investment in oncology R&D, the translation of research advances into medicines that substantially improve the treatment of many cancers remains frustratingly slow. What are the key challenges in anticancer drug development, and how might they be addressed?

Citing Articles

Mimicking women's endocrine milieu in mice for women's health-related studies.

Constantin C, Matvienko D, Laszlo C, Scabia V, Battista L, Binz P NPJ Womens Health. 2025; 3(1):13.

PMID: 39991042 PMC: 11845318. DOI: 10.1038/s44294-025-00060-4.

Intraductal chemotherapy for triple-negative breast cancer: a pathway to minimally invasive clinical treatment.

Wu X, Yuan F, Guo L, Gao D, Zheng W, Chen C BMC Cancer. 2025; 25(1):285.

PMID: 39966717 PMC: 11837698. DOI: 10.1186/s12885-025-13693-0.

Genipin's potential as an anti-cancer agent: from phytochemical origins to clinical prospects.

Natallia L, Dama A, Gorica E, Darya K, Pena-Corona S, Cortes H Med Oncol. 2024; 41(8):186.

PMID: 38918260 DOI: 10.1007/s12032-024-02429-y.

Gaussian accelerated molecular dynamics simulations facilitate prediction of the permeability of cyclic peptides.

Frazee N, Billlings K, Mertz B PLoS One. 2024; 19(4):e0300688.

PMID: 38652734 PMC: 11037548. DOI: 10.1371/journal.pone.0300688.

Food therapy of scutellarein ameliorates pirarubicin‑induced cardiotoxicity in rats by inhibiting apoptosis and ferroptosis through regulation of NOX2‑induced oxidative stress.

Lan Y, Tian F, Tang H, Pu P, He Q, Duan L Mol Med Rep. 2024; 29(5).

PMID: 38516760 PMC: 10979251. DOI: 10.3892/mmr.2024.13208.